Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Diet and supplements can significantly affect acne, with some foods and nutrients reducing and others worsening it.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Psychological factors play a significant role in developing alopecia areata.

DHEA affects various tissues by interacting with multiple receptors and can be converted into sex hormones.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Changes in prolactin and DHEA levels are not required for the start of mink hair growth cycles.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Topical DHEA safely increases skin oil production.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

Yifa compound effectively treats female pattern hair loss and lowers DHT and DHEA levels.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Minoxidil activates hair growth by being sulfated by P-PST in the human liver.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.